HIV drug extension study halted early: what happened?
NCT ID NCT02990858
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether weekly injections of PRO 140, taken with standard HIV medications, could keep the virus under control over the long term. It enrolled 43 people who had already completed an earlier PRO 140 study and had undetectable virus levels. The study was terminated early, so final results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS (HIV) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a psychedelic help break meth addiction in people with HIV?
- Could a diabetes drug turn back the biological clock in HIV?
- New HIV prevention drug faces drug interaction test
- HIV counselors lead new push to offer prevention pills at family planning visits
- Could a vending Machine-Style kiosk curb HIV and overdose deaths in rural america?
- Village health workers lead new HIV prevention effort in lesotho